| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 04/22/2004 | US20040077625 Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake |
| 04/22/2004 | US20040074842 Filtration; for prevention of destruction of catalyst |
| 04/21/2004 | EP1409461A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP0877736B1 Benzazepine derivatives with vasopressin agonistic activity |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/20/2004 | CA2246485C Novel derivatives of indole and indazole, process for their preparation and pharmaceutical compositions containing them |
| 04/15/2004 | WO2004031401A2 Novel tyrosine kinases inhibitors |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
| 04/15/2004 | US20040072827 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 04/15/2004 | US20040072819 Benzoxazepine compounds, their production and use |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP0921800B1 Substituted biphenyl isoxazole sulfonamides |
| 04/14/2004 | CN1489580A Imidazole derivatives |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720428 Reacting a hydrazine derivative with n-dihalogenomethyl-formamidinium halide to form 2-(1,2,4-triazol-1-yl)-ethanols |
| 04/13/2004 | US6720347 Such as ethyl-3-((e)-2-acetamido-thiazol-5-yl)-acrylate for treatment of cancer, proliferative diseases, inflammation, and arthritis |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720323 Colchinol derivatives as angiogenesis inhibitors |
| 04/13/2004 | US6720317 Inhibitors of factor Xa |
| 04/13/2004 | CA2149239C Herbicidal sulfonylureas, their preparation and use |
| 04/08/2004 | US20040067998 Oral administering |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/07/2004 | EP1404696A1 Activators for oligonucleotide synthesis |
| 04/07/2004 | EP1404666A1 4-substituted-picolinic acid amide derivatives useful as fungicides |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1240132B1 Adamantane derivatives |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487920A Deltal-pyrrolines used as pesticides |
| 04/07/2004 | CN1487820A Primary intermediate for oxidative coloration of hair |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2004 | US6716980 Cyclization and acylation of carbamate |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/01/2004 | WO2004026866A1 N-aroyl cyclic amines as orexin receptor antagonists |
| 04/01/2004 | WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis |
| 04/01/2004 | US20040063767 Reacting an alpha-substituted ketone with a cyclictetramine to form quaternaryammonium salt, reacting the salt with an acid to form alpha-amino ketone, reacting ketone with alpha-substitued acyl derivative in presence of a base |
| 04/01/2004 | US20040063737 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
| 04/01/2004 | US20040063584 Benzazolonylcarbonylcyclohexenones and their use ss herbicides |
| 04/01/2004 | DE10243666A1 Dithiocarbaminsäureester Dithiocarbaminsäureester |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 03/31/2004 | EP1401844A2 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same |
| 03/31/2004 | EP1401840A1 Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 03/31/2004 | EP1401806A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486297A Primary intermediates for oxidative coloration of hair |
| 03/30/2004 | US6713481 Crystalline antifungal polymorph |
| 03/30/2004 | US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors |
| 03/25/2004 | WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors |
| 03/25/2004 | WO2004024691A1 Cox-2 inhibiting pyridine derivatives |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/25/2004 | WO2004000214A3 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | CA2493497A1 Cox-2 inhibiting pyridine derivatives |
| 03/24/2004 | EP1400508A1 Dithiocarbamic acid ester |
| 03/24/2004 | EP1399417A1 Method for producing perfluoroalkanesulfonic acid esters |
| 03/24/2004 | EP1399402A1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives |
| 03/24/2004 | EP1399158A1 Aromatase inhibitors as novel veterinary drugs |
| 03/24/2004 | EP1003505B1 Heterocyclic vinylethers against neurological disorders |
| 03/24/2004 | CN1142919C Quinazoline derivatives as antitumor agents |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/18/2004 | US20040053982 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 03/18/2004 | US20040053949 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 03/18/2004 | US20040053926 Triazine compounds |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | DE10241555A1 Verfahren zur Durchführung chemischer Reaktionen in der Flüssigphase in Gegenwart eines Katalysators und eines 1,3-substituierten Imidazoliumsalzes A process for carrying out chemical reactions in the liquid phase in the presence of a catalyst and a 1,3-substituted imidazolium salt |
| 03/17/2004 | EP1398318A1 Process for conducting chemical reactions in a liquid phase in the presence of a catalyst and a 1,3-substituted imidazolium salt |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/11/2004 | WO2004020414A1 Oxytocin inhibitors |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040048908 E.g., 3-(5-(3,4-dichlorophenyl)- 4-isoxazolyl)propan-1-ol; prophylaxis or treatment of diabetes, impaired glucose tolerance or diabetic complications |
| 03/11/2004 | US20040048868 Benzimidazoles |
| 03/11/2004 | US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment. |
| 03/11/2004 | US20040048863 Treating osteoarthritis or rheumatoid arthritis |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/10/2004 | EP1396486A1 Bis-paraphenylendiamine derivatives comprising pyrrolidine groups and their use for the colouration of keratinic fibres |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395580A1 Method for the purification of triazolylmethylepoxides |
| 03/10/2004 | EP1395579A1 Method for producing triazolyl methyl oxiranes |
| 03/10/2004 | EP1395578A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |